Clinical trialNCT02217709CompletedPhase 2Interventional

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

SponsorUniversity of Southern CaliforniaEnrollment26Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase II trial studies phenelzine sulfate in treating patients with prostate cancer that has not spread to other parts of the body and has come back. Phenelzine sulfate is a type of antidepressant that works by decreasing the amount of a protein called monoamine oxidase (MAO). MAO drugs may have an anticancer effect in prostate cancer.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Jean C. Shih, PhD
University of Southern California
Principal Investigator
clinicaltrials.gov ↗
Mitchell Gross, MD
University of Southern California
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Usc Norris Westside Cancer Center
Beverly Hills, California, United States
Los Angeles County-Usc Medical Center
Los Angeles, California, United States
Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
Keck Medical Center of Usc Pasadena
Pasadena, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Phenelzine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Sept 2014
Primary completion: 29 Jun 2020
Completion: 29 Jun 2020
Last update posted: 25 Jun 2026
Registered enrollment: 26
Registry id: NCT02217709

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.